Journal of Pharmaceutics & Pharmacology
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
- Repurposing of adamantanes for the potential prevention or treatment of COVID-19
Butterworth Roger F,
Professor of Medicine,
University of Montreal, Canada
E-mail: rb@enceph.com
S2: Repurposing of Adamantanes for the Potential Prevention or Treatment of COVID-19